Cyclosporine before PCI in Patients with Acute Myocardial Infarction

Cung, Thien-Tri; Morel, Olivier; Cayla, Guillaume; Rioufol, Gilles; García‐Dorado, David; Angoulvant, Denis; Bonnefoy‐Cudraz, Eric; Guérin, Patrice; Elbaz, Meier; Delarche, Nicolas; Coste, Pierre; Vanzetto, Gérald; Metge, M; Aupetit, Jean‐François; Jouve, Bernard; Motreff, Pascal; Tron, Christophe; Labèque, Jean-Noël; Gabríel Steg, Philippe; Cottin, Yves; Rangé, Grégoire; Clerc, J.; J. Claeys, Marc; Coussement, Patrick; Prunier, Fabrice; Moulin, Frédéric; Roth, Olivier; Belle, Loïc; Dúbois, Philippe; Barragan, Paul; Gilard, Martine; Piot, Christophe; Colin, Patrice; De Poli, F.; Morice, Marie‐Claude; Ider, Omar; Dubois‐Randé, Jean‐Luc; Unterseeh, Thierry; Breton, Hervé; Béard, T; Blanchard, Didier; Grollier, Gilles; Malquarti, V.; Staat, Patrick; Sudre, Arnaud; Elmér, Eskil; J. Hansson, Magnus; Bergerot, Cyrille; Boussaha, Inesse; Jossan, Claire; Dérumeaux, Geneviève; Mewton, Nathan; Ovize, Michel

doi:10.1056/nejmoa1505489

Public

Cyclosporine before PCI in Patients with Acute Myocardial Infarction

Published in New England Journal of Medicine • Aug 30, 2015

Authors:

Thien-Tri Cung

Olivier Morel

Guillaume Cayla

Abstract

BACKGROUND: Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling. METHODS: In a multicenter, double-blin...

Subject

Medicine

Myocardial infarction

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!